Monoclonal Antibody-Based Targeted Therapy in Breast Cancer: Current Status and Future Directions

Author： Bernard-Marty Chantal Lebrun Fabienne Awada Ahmad Piccart Martine J.

ISSN： 0012-6667

Source： Drugs, Vol.66, Iss.12, 2006-01, pp. : 1577-1591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiangiogenic Therapy for Metastatic Breast Cancer: Current Status and Future Directions

By Chan Arlene

Drugs, Vol. 69, Iss. 2, 2009-01 ,pp. : 167-181

Adis International

Access to resources Recommend Favorite

Targeted therapy in acute myeloid leukaemia: current status and future directions

By Stapnes Camilla Gjertsen Bjørn Tore Reikvam Håkon Bruserud Øystein

Expert Opinion on Investigational Drugs, Vol. 18, Iss. 4, 2009-04 ,pp. : 433-455

Informa Healthcare

Access to resources Recommend Favorite

Antibody-based cancer therapy

By Baxevanis Constantin N

Expert Opinion on Drug Discovery, Vol. 3, Iss. 4, 2008-04 ,pp. : 441-452

Informa Healthcare

Access to resources Recommend Favorite

Monoclonal Antibody-Based Therapy Strategies: Providing Options for the Cancer Patient

Current Pharmaceutical Design, Vol. 8, Iss. 19, 2002-09 ,pp. : 1749-1764

Bentham Science Publishers

Access to resources Recommend Favorite

Targeted Approaches to Triple-Negative Breast Cancer: Current Practice and Future Directions

Current Medicinal Chemistry, Vol. 20, Iss. 5, 2013-02 ,pp. : 605-612

Bentham Science Publishers

Access to resources Recommend Favorite